OTC · Medical - Specialties

Nanalysis Scientific Corp. (NSCIF) Stock

$0.09 +0.00% OTC: NSCIF Healthcare

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally.

Valuation

MetricValue
Price$0.09
Market Cap$10.38M
P/E Ratio-2.72
P/B Ratio1.34
P/S Ratio0.36
EPS (TTM)$-0.05
52-Week High$0.18
52-Week Low$0.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-44.82%
ROA-16.06%
ROCE-17.05%
Gross Margin21.89%
Operating Margin-8.89%
Net Margin-14.01%
Debt/Equity1.15
Current Ratio1.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$16.0M$25.0M$28.0M$45.0M$40.0M
Operating Profit$-1.0M$-10.0M$-12.0M$-3.0M$-4.0M
Net Profit$-2.0M$-10.0M$-17.0M$-14.0M$-6.0M
EPS$-0.03$-0.11$-0.16$-0.12$-0.05
Op Margin-7.4%-39.9%-40.8%-7.6%-9.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$38.0M$70.0M$54.0M$42.0M$38.0M
Total Liabilities$14.0M$22.0M$30.0M$27.0M$25.0M
Cash$10.0M$4.0M$1.0M$1.0M$1.0M
Borrowings$6.0M$11.0M$22.0M$18.0M$18.0M

Latest News

Nanalysis Announces Grant of Options and Restricted Share Units PR Newswire · Jul 3, 2026 Nanalysis Scientific Broadens NVision Collaboration, Receives $1 Million Government Contribution MT Newswires · Jun 23, 2026 Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, Contract Wins and Corporate Activities CNW Group · Jun 23, 2026 Nanalysis Scientific Posts Narrower Loss, Higher Revenue for First Quarter MT Newswires · May 20, 2026 Nanalysis Announces First Quarter 2026 Results PR Newswire · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-9.0M$-11.0M$3.0M$3.0M
Investing Cash Flow$-6.0M$-19.0M$-11.0M$-4.0M$-4.0M
Financing Cash Flow$10.0M$14.0M$4.0M$3.0M$2.0M
Net Cash Flow$7.0M$-7.0M$-3.0M$1.0M$2.0M
Free Cash Flow$-4.0M$-16.0M$-16.0M$1.0M$2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.05
EV / EBITDA-32.95
FCF Yield-5.89%
Quick Ratio0.75
Interest Coverage-2.52
Return 1Y-45.83%
Return 3Y-80.10%
Return 5Y—

Ownership

Insiders Held4.15%
Institutions Held7.04%
Institutions Float Held7.34%
Institutional HolderSharesReport Date
MAI Capital Management30,0002024-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Nanalysis Scientific Corp.

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.

Nanalysis Scientific Corp. is headquartered in CA.

Nanalysis Scientific Corp. (NSCIF) stock trades at $0.09 with a market capitalization of $10.38M. The stock is valued at a price-to-earnings (P/E) ratio of -2.72, price-to-book of 1.34, price-to-sales of 0.36. Over the past 52 weeks the stock has ranged between $0.08 and $0.18, and currently trades 50.0% below its 52-week high.

On profitability, Nanalysis Scientific Corp. generates a return on equity (ROE) of -44.82%, return on capital employed of -17.05%, an operating margin of -8.89%, a net profit margin of -14.01%.

Official website: www.nanalysis.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides